![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1423-0399|98|2|184-190
ISSN: 0042-1138
Source: Urologia Internationalis, Vol.98, Iss.2, 2016-03, pp. : 184-190
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Duration of Targeted Therapy for Metastatic Renal Cell Carcinoma: A Review of Current Practices
Oncology, Vol. 82, Iss. 4, 2012-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Continuous Therapy with Sunitinib in Patients with Metastatic Renal Cell Carcinoma
Oncology Research and Treatment, Vol. 31, Iss. 8-9, 2008-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeted therapy after metastasectomy
INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 2, 2015-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeted Therapy in the Treatment of Metastatic Renal Cell Cancer
Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. :